BCAX Annual FCF
-$46.21 M
-$13.95 M-43.22%
01 December 2023
Summary:
As of January 23, 2025, BCAX annual free cash flow is -$46.21 million, with the most recent change of -$13.95 million (-43.22%) on December 1, 2023. During the last 3 years, it has fallen by -$13.95 million (-43.22%). BCAX annual FCF is now -43.22% below its all-time high of -$32.27 million, reached on December 1, 2022.BCAX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX Quarterly FCF
-$17.23 M
0.00%
30 September 2024
Summary:
As of January 23, 2025, BCAX quarterly free cash flow is -$17.23 millionOver the past year, it has dropped by -$6.55 million (-61.32%). BCAX quarterly FCF is now -61.32% below its all-time high of -$10.68 million, reached on September 30, 2023.BCAX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX TTM FCF
-$17.23 M
0.00%
30 September 2024
Summary:
As of January 23, 2025, BCAX TTM free cash flow is -$17.23 millionOver the past year, it has dropped by -$6.55 million (-61.32%). BCAX TTM FCF is now -61.32% below its all-time high of -$10.68 million, reached on September 30, 2023.BCAX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -43.2% | -61.3% | -61.3% |
| 3 y3 years | -43.2% | -61.3% | -61.3% |
| 5 y5 years | -43.2% | -61.3% | -61.3% |
BCAX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -43.2% | at low | -61.3% | at low | -61.3% | at low |
| 5 y | 5-year | -43.2% | at low | -61.3% | at low | -61.3% | at low |
| alltime | all time | -43.2% | at low | -61.3% | at low | -61.3% | at low |
Bicara Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$17.23 M(+61.3%) | -$17.23 M(+61.3%) |
| Dec 2023 | -$46.21 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$10.68 M | -$10.68 M |
| Dec 2022 | -$32.27 M | - | - |
FAQ
- What is Bicara Therapeutics annual free cash flow?
- What is the all time high annual FCF for Bicara Therapeutics?
- What is Bicara Therapeutics annual FCF year-on-year change?
- What is Bicara Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Bicara Therapeutics?
- What is Bicara Therapeutics quarterly FCF year-on-year change?
- What is Bicara Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Bicara Therapeutics?
- What is Bicara Therapeutics TTM FCF year-on-year change?
What is Bicara Therapeutics annual free cash flow?
The current annual FCF of BCAX is -$46.21 M
What is the all time high annual FCF for Bicara Therapeutics?
Bicara Therapeutics all-time high annual free cash flow is -$32.27 M
What is Bicara Therapeutics annual FCF year-on-year change?
Over the past year, BCAX annual free cash flow has changed by -$13.95 M (-43.22%)
What is Bicara Therapeutics quarterly free cash flow?
The current quarterly FCF of BCAX is -$17.23 M
What is the all time high quarterly FCF for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly free cash flow is -$10.68 M
What is Bicara Therapeutics quarterly FCF year-on-year change?
Over the past year, BCAX quarterly free cash flow has changed by -$6.55 M (-61.32%)
What is Bicara Therapeutics TTM free cash flow?
The current TTM FCF of BCAX is -$17.23 M
What is the all time high TTM FCF for Bicara Therapeutics?
Bicara Therapeutics all-time high TTM free cash flow is -$10.68 M
What is Bicara Therapeutics TTM FCF year-on-year change?
Over the past year, BCAX TTM free cash flow has changed by -$6.55 M (-61.32%)